InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 31 Jul 2008 9:30AM $0.310 $0.010 fallen by 96.77%
- BNO Completes GMP Synthesis of BNC210 9 Jul 2008 9:57AM $0.325 $0.010 fallen by 96.92%
- Open Briefing - BNO. Merck Serono Development Agreement 24 Jun 2008 9:10AM $0.365 $0.010 fallen by 97.26%
- Merck Serono and BNO announce MS Agreement 19 Jun 2008 9:38AM $0.380 $0.010 fallen by 97.37%
- Trading Halt 18 Jun 2008 9:47AM n/a $0.010 n/a
- Appendix 4C - quarterly 29 Apr 2008 3:42PM $0.360 $0.010 fallen by 97.22%
- BNO - BNC210 Manufacture Contract Awarded 16 Apr 2008 9:47AM $0.350 $0.010 fallen by 97.14%
- BNO Presents at AACR 14 Apr 2008 10:06AM n/a $0.010 n/a
- Bionomics Advances Anti-Anxiety Candidate BNC210 11 Mar 2008 11:43AM $0.330 $0.010 fallen by 96.97%
- Open Briefing - BNO. Phase I Clinical Trials of BNC105 27 Feb 2008 11:03AM $0.405 $0.010 fallen by 97.53%
- Appendix 4D 20 Feb 2008 9:31AM $0.345 $0.010 fallen by 97.10%
- GENMAB MILESTONE PAYMENT 19 Feb 2008 9:47AM $0.370 $0.010 fallen by 97.30%
- Appendix 4C - quarterly 31 Jan 2008 3:55PM $0.310 $0.010 fallen by 96.77%
- Bionomics Gains IND Approval 22 Nov 2007 1:42PM $0.375 $0.010 fallen by 97.33%
- Trading Halt 22 Nov 2007 9:46AM $0.375 $0.010 fallen by 97.33%
- Appendix 4C - quarterly 31 Oct 2007 11:28AM $0.360 $0.010 fallen by 97.22%
- Latest Data Presented at International Conference 5 Oct 2007 9:19AM $0.395 $0.010 fallen by 97.47%
- Appendix 4E 29 Aug 2007 9:38AM $0.300 $0.010 fallen by 96.67%
- Bionomics to Develop Cancer Drug Target BNO69 6 Aug 2007 9:19AM $0.330 $0.010 fallen by 96.97%
- Appendix 4C - quarterly 30 Jul 2007 10:14AM $0.360 $0.010 fallen by 97.22%
- Raises $10 Million in Private Placement 20 Jun 2007 3:23PM $0.395 $0.010 fallen by 97.47%
- Trading Halt 20 Jun 2007 10:03AM $0.395 $0.010 fallen by 97.47%
- Open Briefing - Bionomics Pipeline Update 4 Jun 2007 12:03PM $0.320 $0.010 fallen by 96.88%
- Validates Third Cancer Application for Compound BNC105 4 Jun 2007 8:44AM $0.320 $0.010 fallen by 96.88%
- Bionomics Validates Drug Candidate for Anxiety 29 May 2007 8:52AM $0.285 $0.010 fallen by 96.49%

701 - 725 of 801 results

Page 29 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.